Acuamark Diagnostics is Diagnostic Equipment in United States that focus on early detection business. Founded in 2013. They cover business area such as developer, blood technology, cancer marker, early stage, a suite, highly novel, cut-edge multiplexed assay, several level, molecular change, doctor, result, blood-base screening, early detection.
2013
( 11 years old in 2024 )
Early Detection
-
101 Avenue Of The Americas
3rd Floor (c/o JLabs)
New York, NY 10013
United States
Private
developerblood technologycancer markerearly stagea suitehighly novel, cut-edge multiplexed assayseveral levelmolecular changedoctorresultblood-base screeningearly detection
* We use standard office opening hours in near Acuamark Diagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Acuamark Diagnostics is Diagnostic Equipment business from United States that founded in 2013 (11 years old in 2024), Acuamark Diagnostics business is focusing on Early Detection.
Acuamark Diagnostics headquarter office and corporate office address is located in 101 Avenue Of The Americas 3rd Floor (c/o JLabs) New York, NY 10013 United States.
Acuamark Diagnostics was founded in United States.
In 2024, Acuamark Diagnostics is currently focus on early detection sector.
Above is snippet of Google Trends for "early detection" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Acuamark Diagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
